- Supporting drug development research through the use of HCA and three-dimensional culture models -
- Integration with Yokogawa portfolio makes possible a “sensor-to-enterprise” solution for solar, wind, and energy storage projects -
An enhanced release of an OpreX Operational Risk Management family product that supports a wider range of devices, enabling hands-free field inspections
Collaborating with coronavirus researchers, Yokogawa's Life Innovation business is supporting the development of new medication and vaccines.
Introducing how sensing technology can be applied to generate greater innovations, and looking at the challenges ahead.
By acquiring the necessary data and providing continuous industrial process analysis, Yokogawa's solutions enable customers to solve their most pressing challenges.
KBC identifies, implements and sustains operational excellence for our customers.